MENU

Drug Development

At Usona, we continually invest in our Drug Development programs to strengthen our capabilities and extend our global reach. Usona is leveraging state-of-the art science to develop drug therapies and accompanying supportive therapeutic framework for challenging mental health conditions.

We currently have two drug development programs in the clinical stage.

Phases of a Clinical Trial Process | 5-MeO-DMT is at beginning of phase one and psilocybin is in between phase 2 and 3

Psilocybin

Usona is currently exploring the therapeutic potential of psilocybin in the treatment of major depressive disorder (MDD).

Psilocybin
Close up of psilocybin crystallization

5-MeO-DMT

Usona has completed the preclinical safety studies required by the US FDA and has recently been granted authorization to proceed to clinical trials in healthy volunteers.

LEARN MORE ABOUT 5-MeO-DMT
Beakers cropped into a circle.